Viekirax (ombitasvir, paritaprevir, ritonavir) with or without Exviera (dasubuvir) - Important Safety Information from AbbVie Ltd. as approved by the HPRA

Notice type: 3rd Party Publications

Date: 05/01/2016

Problem Or Issue:
Important Safety Information communication from AbbVie Ltd. - Viekirax, with or without Exviera: not recommended in Child-Pugh B patients.

Important Safety Information - Viekirax (ombitasvir, paritaprevir, ritonavir) with or without Exviera (dasubuvir)

« Back